Clover Health Investments, Corp. (CLOV)

Clover Health Investments Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Clover Health Investments stock has a consensus rating of "Buy" and an average price target of $4.15. The average 1-year stock price forecast is 13.72% lower than the current stock price, while the lowest is $3.50 (-27.23%) and the highest is $4.75 (-1.25%).

Price Target: $4.15 (-13.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.50	$4.15	$4.20	$4.75
Change	-27.23%	-13.72%	-12.68%	-1.25%

Analyst Ratings

The average analyst rating for Clover Health Investments stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Yong UBS	UBS	Hold Maintains $2.75 → $4.75	Hold	Maintains	$2.75 → $4.75	-1.25%	Jun 11, 2026
Richard Close Canaccord Genuity	Canaccord Genuity	Buy Maintains $3.2 → $4.2	Buy	Maintains	$3.2 → $4.2	-12.68%	Jun 4, 2026

Financial Forecast

Revenue This Year

2.91B

Increased by 51.30%

from 1.92B

Revenue Next Year

3.32B

Increased by 14.19%

from 2.91B

EPS This Year

0.09

Increased by 130.77%

from 0.04

EPS Next Year

0.10

Increased by 11.11%

from 0.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.36B	1.20B	1.26B	1.37B	1.92B	2.91B
Revenue Growth	97.30%	-11.91%	5.32%	8.52%	40.33%	51.30%
Net Income	-587.76M	-339.57M	-213.36M	-43.01M	-85.55M	6.42M
EPS	-	-	-	-	0.04	0.09
EPS Growth	-	-	-	-	-	130.77%
Forward PE	-	-	-	-	-	53.44
Free Cash Flow	-354.93M	-21.71M	68.75M	200.78M	-37.40M	-66.36M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	2.9B
Avg	2.9B
Low	2.9B

Revenue Growth

Revenue Growth	2026	2027	2028
High	51.8%
Avg	51.3%
Low	50.6%

EPS Forecast

EPS	2026	2027	2028
High	0.09
Avg	0.09
Low	0.09

EPS Growth

EPS Growth	2026	2027	2028
High	130.8%
Avg	130.8%
Low	130.8%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Jun 11, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Last checked:

Jun 11, 2026

Data Sources Report a data error